ArticleBMC microbiology2026
Green synthesis of TiO₂ nanoparticles using cyanobacterial phycobiliproteins for antibacterial and antioxidant toothpaste applications.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral diseases such as dental caries are highly prevalent and are strongly associated with microbial biofilms and oxidative stress. This study investigated the green synthesis of titanium dioxide nanoparticles (TiO₂ nanoparticles) using cyanobacterial phycobiliproteins, including phycocyanin (PC) and phycoerythrin (PE), extracted from Trichormus sp. 121B and Desmonostoc alborizicum. Spectrophotometric analysis confirmed nanoparticle formation, while Fourier Transform Infrared (FTIR) analysis indicated the presence of organic functional groups derived from cyanobacterial pigments. Dynamic Light Scattering (DLS) analysis showed an average nanoparticle size of approximately 122 nm. The toothpaste formulation containing 2% TiO₂ nanoparticles exhibited the highest antibacterial activity, with inhibition zones of 12.33 ± 0.33 mm against S. mutans, 15.33 ± 0.33 mm against Staphylococcus aureus, and 11.33 ± 0.33 mm against Escherichia coli, compared to no activity in the control group. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) values against S. mutans were reduced by 75% and 80%, respectively. Total phenolic content and antioxidant activity were also better preserved, with approximately 22% higher 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging activity and 17% higher Fourier Transform Infrared (FTIR) values compared to the control. Sensory evaluation confirmed strong acceptability of the 2% nanoparticle toothpaste formulation. Overall, incorporation of 2% biosynthesized TiO₂ nanoparticles significantly enhanced antibacterial efficacy, antioxidant preservation, formulation stability, and sensory properties, demonstrating a clear dose-dependent improvement across all evaluated parameters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.